QQ客服 官方微博 反馈留言

	MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway
	Li, Yue; Zhang, Shihong; Wang, Yuanjian; Peng, Jin; Fang, Fang; Yang, Xingsheng
刊名	BMC CANCER
	2018
卷号	18期号:1
关键词	Endometrial carcinoma siRNA-MLH1 ADV-MLH1 Cisplatin sensitivity Individualized therapy
DOI	10.1186/s12885-018-5218-4
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4570755
专题	山东大学
作者单位	1.Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, 107,Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China. 2.[
推荐引用方式 GB/T 7714	Li, Yue,Zhang, Shihong,Wang, Yuanjian,et al. MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway[J]. BMC CANCER,2018,18(1).
APA	Li, Yue,Zhang, Shihong,Wang, Yuanjian,Peng, Jin,Fang, Fang,&Yang, Xingsheng.(2018).MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway.BMC CANCER,18(1).
MLA	Li, Yue,et al."MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway".BMC CANCER 18.1(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。